Have we learnt all we need to know from genetic studies - Is genetics over in Alzheimer's disease?

Alzheimer's Research and Therapy

Volumn 5, Issue 2, 2013, Pages

  Hampel, Harald ^a,b   Lista, Simone ^c  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL MEMBRANE; CHOLESTEROL METABOLISM; FAMILIAL DISEASE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENETICS; HERITABILITY; HUMAN; LIPID METABOLISM; ONSET AGE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 84873948290     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt165     Document Type: Article

References (20)

1. The genetics of Alzheimer disease: back to the future. Bertram L, Lill CM, Tanzi RE, Neuron 2010 68 270 281 10.1016/j.neuron.2010.10.013 20955934
2. Alzheimer disease: From inherited to sporadic AD-crossing the biomarker bridge. Hampel H, Lista S, Nat Rev Neurol 2012 8 598 600 10.1038/nrneurol.2012. 202 23007701
3. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE, Nat Genet 2007 39 17 23 10.1038/ng1934 17192785 (Pubitemid 46026496)
4. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, et al. Nat Genet 2009 41 1088 1093 10.1038/ng.440 19734902
5. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fiévet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, European Alzheimer's Disease Initiative Investigators, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, et al. Nat Genet 2009 41 1094 1099 10.1038/ng.439 19734903
6. Genome-wide analysis of genetic loci associated with Alzheimer disease. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC, Harold D, Schrijvers EM, Ramirez-Lorca R, Debette S, Longstreth WT Jr, Janssens AC, Pankratz VS, Dartigues JF, Hollingworth P, Aspelund T, Hernandez I, Beiser A, Kuller LH, Koudstaal PJ, Dickson DW, Tzourio C, Abraham R, Antunez C, Du Y, Rotter JI, Aulchenko YS, et al. JAMA 2010 303 1832 1840 10.1001/jama.2010.574 20460622
7. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, et al. Nat Genet 2011 43 429 435 10.1038/ng.803 21460840
8. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, et al. Nat Genet 2011 43 436 441 10.1038/ng.801 21460841
9. Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease. Zetzsche T, Rujescu D, Hardy J, Hampel H, Expert Rev Mol Diagn 2010 10 667 6990 10.1586/erm.10.48 20629514
10. A new testing strategy to identify rare variants with either risk or protective effect on disease. Ionita-Laza I, Buxbaum JD, Laird NM, Lange C, PLoS Genet 2011 7 1001289 10.1371/journal.pgen.1001289 21304886
11. Synthetic associations created by rare variants do not explain most GWAS results. Wray NR, Purcell SM, Visscher PM, PLoS Biol 2011 9 1000579 10.1371/journal.pbio.1000579 21267061
12. Impact of diagnostic misclassification on estimation of genetic correlations using genome-wide genotypes. Wray NR, Lee SH, Kendler KS, Eur J Hum Genet 2012 20 668 674 10.1038/ejhg.2011.257 22258521
13. Variant of TREM2 associated with the risk of Alzheimer's disease. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K, N Engl J Med 2013 368 107 116 10.1056/NEJMoa1211103 23150908
14. TREM2 variants in Alzheimer's disease. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J, Alzheimer Genetic Analysis Group, N Engl J Med 2013 368 117 127 10.1056/NEJMoa1211851 23150934
15. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jönsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K, Nature 2012 488 96 99 10.1038/nature11283 22801501
16. The role of genetics for biomarker development in neurodegeneration. Bertram L, Hampel H, Prog Neurobiol 2011 95 501 504 10.1016/j.pneurobio.2011.09. 011 22005514
17. A map of human genome variation from population-scale sequencing. 1000 Genomes Project Consortium, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA, Nature 2010 467 1061 1073 10.1038/nature09534 20981092
18. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K, Nat Rev Drug Discov 2010 9 560 574 10.1038/nrd3115 20592748
19. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot. Hampel H, Lista S, Khachaturian ZS, Alzheimers Dement 2012 8 312 336 10.1016/j.jalz.2012.05.2116 22748938
20. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC, Dominantly Inherited Alzheimer Network, N Engl J Med 2012 367 795 804 10.1056/NEJMoa1202753 22784036